Updated Jul 16, 2026 · Last SEC filing 2026-06-08
Aclaris Therapeutics, Inc. (ACRS) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-08. 3 Form 8-K material event filings were reported by ACRS in the last 90 days. InsiderAlpha tracks every ACRS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001557746 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-06-08 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mehra Anand | Insider | M — Option exercise | 11.6K | — | — | SEC | |
| Humphries William D. | Insider | M — Option exercise | 11.6K | — | — | SEC | |
| GOWEN MAXINE | Insider | M — Option exercise | 11.6K | — | — | SEC | |
| MILANO VINCENT | Insider | M — Option exercise | 11.6K | — | — | SEC | |
| Molineaux Christopher P. | Insider | M — Option exercise | 11.6K | — | — | SEC | |
| SCHIFF ANDREW N | Insider | M — Option exercise | 11.6K | — | — | SEC | |
| Hall Jesse Wayne | Chief Medical Officer | M — Option exercise | 36.4K | — | — | SEC | |
| Hall Jesse Wayne | Chief Medical Officer | F — Tax withholding / forfeiture | 9.3K | $4.41 | $41K | SEC | |
| Leonard Braden Michael | Insider | S — Open-market sale | 300.0K | $4.53 | $1.36M | SEC | |
| Balthaser Kevin | Chief Financial Officer | F — Tax withholding / forfeiture | 677 | $2.87 | $2K | SEC | |
| Balthaser Kevin | Chief Financial Officer | M — Option exercise | 2.4K | — | — | SEC | |
| Walker Neal | CEO | M — Option exercise | 63.5K | — | — | SEC | |
| Balthaser Kevin | Chief Financial Officer | M — Option exercise | 22.0K | — | — | SEC | |
| Walker Neal | CEO | F — Tax withholding / forfeiture | 18.6K | $3.47 | $65K | SEC | |
| Balthaser Kevin | Chief Financial Officer | F — Tax withholding / forfeiture | 6.4K | $3.47 | $22K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Aclaris Therapeutics, Inc. (ACRS). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Molineaux Christopher P. | 4 | — |
| MILANO VINCENT | 4 | — |
| SCHIFF ANDREW N | 4 | — |
| GOWEN MAXINE | 4 | — |
| Mehra Anand | 4 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ACRS insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ACRS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.